✓ Last verified: April 27, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Headlight (formerly Achieve Medical) in Wasilla offers Spravato (esketamine nasal spray) alongside talk therapy and medication management for treatment-resistant depression. As part of the Headlight Health network, this Mat-Su Valley location provides both in-person and virtual mental health services with in-network insurance acceptance through most major providers.
| Google Reviews | Limited reviews available |
| Location | Wasilla, Alaska |
| Address | 1981 East Palmer Wasilla Hwy, Suite 230, Wasilla, AK 99654 |
| Phone | (907) 802-2493 |
| Website | headlight.health |
| Treatments | Spravato (esketamine nasal spray), talk therapy, medication management |
| Conditions Treated | Treatment-resistant depression, anxiety, PTSD, OCD, bipolar disorder, ADHD |
| Cost | Average $30 copay for in-network patients |
| Insurance | In-network with most major providers |
| KAP Available | Not indicated |
| Clinical Lead | Contact clinic for provider details |
HealingMaps Take: The Wasilla Headlight location extends access to Spravato treatment into the Mat-Su Valley, serving patients who might otherwise face a long drive to Anchorage. Insurance coverage through most major providers keeps costs manageable—an average $30 copay is substantially less than typical out-of-pocket ketamine infusion costs. The combined offering of esketamine, therapy, and medication management creates a comprehensive treatment approach. Note that this clinic offers Spravato (nasal esketamine) rather than IV ketamine infusions.
Market Position: Headlight (Previously Achieve Medical) is a Spravato-certified clinic in the Wasilla metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Industry pricing reference. Headlight (Previously Achieve Medical)’s posted price: Average $30 copay for in-network patients. Contact the clinic for any package or sliding-scale options. The calculator above shows metro-level cost estimates across protocols.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Alaska, state-level prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
Published IV ketamine pricing runs 15–25% higher than what patients actually pay: the median published rate is $525 versus a patient-reported median of $350. Patients who ask about sliding-scale or package pricing often find meaningful flexibility. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 4-question summary is matched to the protocols and conditions Headlight (Previously Achieve Medical) treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Headlight (Previously Achieve Medical) offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Headlight (Previously Achieve Medical) treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — Headlight (Previously Achieve Medical) treats PTSD. Spravato can be used for trauma. Ketamine for trauma differs from depression treatment: dosing is often lower per session, and pairing the protocol with trauma-focused therapy between sessions is common. A reasonable consult question: whether PTSD patients here typically use ketamine alone or alongside an outside therapist.
Yes — Headlight (Previously Achieve Medical) treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
View all REMS-certified Spravato clinics in Alaska and across the United States.
Leave a Reply